Navigation Links
Novel mechanism revealed for increasing recombinant protein yield in tobacco
Date:8/8/2009

Elastin-like polypeptides (ELPs) cause plants to store GM proteins in special 'protein bodies', insulating them from normal cellular degradation processes and increasing the overall protein yield. Researchers writing in the open access journal BMC Biology have visualised the mechanism by which the synthetic biopolymer increases the accumulation of recombinant proteins.

Rima Menassa worked with a team of researchers from Agriculture and Agri-Food Canada in London, Ontario, to develop and test the ELP tags by targeting an ELP-green fluorescent protein (GFP) fusion to various organelles in the leaves of the tobacco plant. Tobacco is well-suited as a production system for recombinant proteins but the mechanism by which ELP fusions increase production yields in transgenic tobacco leaves was previously unknown. Menassa said, "ELP was shown to almost double the yield of GFP to 11% of total soluble protein when hyperexpressed in the endoplasmic reticulum (ER)".

Based on their confocal and electron microscopy analyses, the researchers suggest that ELP fusions targeted to the ER induce the formation of novel mobile protein body-like structures in leaves, which appear similar in size and morphology to the prolamin-based protein bodies naturally found in plant seeds. These bodies may be responsible for ELP's positive effect on recombinant protein accumulation by excluding the heterologous protein from normal physiological turnover.

The researchers targeted their ELP fusions to the cytoplasm, chloroplasts, apoplast and ER in Nicotiana benthamiana tobacco plants. They found that the ER was the only intracellular compartment in which the ELP significantly enhanced recombinant protein accumulation. They conclude, "An ER-targeted ELP fusion approach provides an effective strategy for depositing large amounts of concentrated heterologous protein within the limited space of the cell".


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-203-192-2165
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. La Jolla Institute discovers novel tumor suppressor
2. Got zinc? New zinc research suggests novel therapeutic targets
3. Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
4. Novel handheld device detects anthrax with outstanding accuracy and reliability
5. International collaboration by scientists culminates in novel ion channels database
6. UC Davis grant zeroes in on novel asthma diagnosis and treatment
7. Novel vaccine approach offers hope in fight against HIV
8. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
9. Study finds novel genetic risk factors for kidney disease
10. Novel antibody prevents infection by hepatitis C virus
11. IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2020)... ... February 26, 2020 , ... ... and Rebound PRF® devices are now available to veterinary practices through Covetrus. ... devices, that will provide the most affordable, easiest to use, multi-species validated, ...
(Date:2/28/2020)... ... February 27, 2020 , ... Regen Suppliers is now offering the ... PDO thread lift products are not only one of the only FDA Cleared ... lift procedures are increasing exponentially in popularity, as they represent an excellent nonoperative method ...
(Date:2/28/2020)... ... February 28, 2020 , ... ... biologics orders. This includes all available stem cell and exosome biologics. , Regen ... tissue, Exosome Biologics, PRP kits, adipose kits, PDO thread lifts and more. ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... March 18, 2020 , ... Family counsellors, marriage/couples therapists, and ... insight into their perceptions of events. Imagine if a couple’s counsellor could see ... could measure the level of engagement of each individual in the therapeutic process, ...
(Date:3/10/2020)... ... March 10, 2020 , ... Ortho Clinical Diagnostics, a ... laboratory solutions, announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen in a ... cleared to run on ORTHO VISION® and ORTHO VISION® Max in the United States ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... and services, today announced the launch of its FleXpress™ high-throughput recombinant antibody ... number of antibodies at 80 ml scale. All production occurs in Absolute ...
(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... ... was invited to present the latest breast implant technology at the IMCAS Innovation ... and new innovations in the dermatology, plastic surgery, and aesthetic science industries that ...
Breaking Biology Technology: